Wounds are being classed as acute and chronic. There are standard and sophisticated wound care and closure solutions for their treatment. Chronic wounds are the wounds that are hard to heal, require extensive time to cure, and are expensive to treat. Advanced wound care and closure solutions are developing as a common method for treating chronic wounds. Many firms in this sector are seeking to increase their product portfolio in order to top this Industry. The major firms are purchasing other companies in this industry as their plan to control this market.
In 2021, the Europe advanced wound dressing market size is expected to reach a valuation of USD 2,700 million by 2030, growing at a CAGR of 4% during the forecast period (2022–2030). The term "advanced wound care" refers to the provision of medical supplies for the treatment of both acute and chronic wounds, including lesions, burns, and post-operative injuries. The advanced wound care therapies such as film and foam dressings, hydrogels, alginates, and hydrocolloids keep the wound moist and expedite the healing process without interfering with the process. People who suffer from chronic wounds can be assisted by the advanced wound care sector, which can provide these patients with goods that are convenient to get, affordable, and suitable for usage at the patients' own discretion. Chronic wounds are growing more prevalent, as are surgeries, and technology developments are driving the industry ahead. The market is being driven forward by technical breakthroughs.
Treatment of advanced wounds dressing goods are a sort of dressing products that are specifically designed for the treatment of both acute and chronic wounds. Healing a chronic wound might take far longer than an acute one and is associated with higher medical costs. This method of treating wounds is quickly becoming the gold standard for the treatment of chronic wounds. People who live with chronic wounds, which are typically time-consuming and expensive to treat, can now find some relief because to technological advancements in wound care equipment. In this respect, technological advancement has made great development. Because they promote faster healing of chronic wounds, advanced wound care products are rapidly displacing their more conventional equivalents in the medical industry.
Patients who suffer from chronic wounds are the target audience for the advanced wound care industry, which provides treatments that are easy to obtain and affordable. The treatment for advanced wound care includes intervention therapies and products such as collagen products, hydrocolloids, antimicrobial dressings, foam dressings, alginate dressings, gauze composites, film dressings, and hydrogels. Other types of dressings include foam dressings, gauze composites, and film dressings. Patients in North America who are affected with chronic wounds are seeing an improvement in their quality of life as a result of the rapidly advancing and increasingly user-friendly technologies.
Get more information on this report Download Sample Report
The rising incidence of injured wounds, the rising prevalence of diabetes, and the growing number of surgical procedures such as caesarean sections and others are the primary factors propelling growth in the advanced wound care market in the European region. Other factors contributing to this growth include the growing number of surgeries overall. Over the past few years, the growth of the advanced wound care market has been accomplished through the introduction of new drugs and products, the mergering and collaboration of various stakeholders and key players, and advancements in technology towards superior wound care products. Additionally, the market expansion has been enabled by the development of new technologies. Having exceptional information regarding the management of wounds, as well as an expanding number of claims for wound care, is driving the surge in market expansion in the United Kingdom. The number of wound cases in the UK is increasing at the greatest compound annual growth rate (CAGR), and each year around 2.2 million individuals in the UK are discovered to have a wound.
The Europe market is primarily driven by an ageing population, as well as rising rates of chronic wounds and diabetes, technology advancements, rising hospital expenses, and government regulations. The incidences of several kinds of ulcers, including Pressure Ulcers, leg Ulcers, foot Ulcers, and so on, can range anywhere from 0.07 percent to 0.09 percent. In addition, chronic wounds affect just 0.24 percent of the population in Europe. As of the year 2018, around 19 percent of the population in Europe were individuals aged 65 and over. By the year 2100, the proportion of persons aged 80 or older is projected to have more than doubled, reaching 14.6 percent of the total population. The elderly population served as a key factor in the development of this sector.
The number of surgical treatments has been steadily rising over the past several years. A number of operations, including hip implant surgeries, major peritoneal surgeries, thoracic surgeries, and ENT operations, as well as operations on the central nervous system, were performed. There has been an increase in the number of inquiries regarding the expeditious healing of wounds. In place of sutures, specialised medical staplers called surgical staplers are used to close wounds during wound closure procedures. As a result of the increased demand for less invasive operations, the market for surgical staplers has expanded in recent years.
The market in Europe is being held back by a number of challenges, including problems with pricing and reimbursement. The insufficient regulations regarding reimbursement that have been implemented by the government are one of the factors that are slowing down the rate of market expansion. The costs involved in carrying out the surgery are rather pricey.
The worldwide advanced wound dressing market is divided into four categories: product, application, end-user, and geography.
Foam, hydrocolloid, film, alginate, hydrogel, collagen, and other advanced dressings make up the worldwide advanced wound dressing market. In 2021, the hydrocolloid dressing segment had a considerable market share, and it is expected to increase at the quickest rate throughout the projected period. At a CAGR of 5%, it is predicted to reach a total value of USD 2,080 million by 2030. Gel-forming materials including carboxymethylcellulose (CMC) and gelatin are used in hydrocolloid dressings. These materials are occlusive, which aids in the retention of moisture. These dressings promote rapid healing and are bacterial infection resistant. As a result, both inside and externally, it helps to protect wounds.
Furthermore, throughout the projection period, rising diabetes incidence around the world are predicted to boost category growth. In 2015, about 5% of individuals in the United States were diagnosed with Type 1 diabetes, according to the CDC. Diabetic sores or diabetic ulcers affect around 15% of the diabetic population. As a result, throughout the projection period, demand for hydrocolloid wound dressing is expected to rise.
The worldwide Europe advanced wound dressing market is segmented into chronic and acute wounds based on application. In 2021, the acute wound segment had the greatest market share. At a CAGR of 4.5 percent, it is predicted to reach a value of USD 6,430 million by 2030. Surgical and traumatic wounds, as well as burns, are among the acute wounds. Due to the rising number of instances of trauma in the United States, the surgical and traumatic wounds category had the biggest proportion. According to the World Health Organization (WHO), trauma accounts for around 9% of worldwide mortality in 2019.
Hospitals, specialised clinics, home healthcare, and others are among the end-users in the worldwide advanced wound dressing market. The market was dominated by the hospital segment. At a CAGR of 4.5 percent, it is predicted to reach a value of USD 4,850 million by 2030. The key category expansion driver is the increased prevalence of diabetic foot ulcers and venous leg ulcers. Furthermore, as the number of procedures grows, the chance of surgical wounds grows, driving the sector ahead. Advanced wound dressing is frequently used to treat SSI wounds. As a result, such factors may help to improve segment growth throughout the forecasted term.
Country wise Growth Insights Request Sample Pages
The Europe advanced wound dressing market in Europe is propelled forward by a number of factors, including the existence of an advanced healthcare infrastructure and the accessibility of qualified specialists. At a compound annual growth rate of 4%, it is anticipated to reach 2,700 million US dollars by the year 2030. In addition, good payment coverage has led to a rise in the number of surgical operations being performed. A growing elderly population as well as an increase in the number of people who have suffered burns and traumatic injuries are also expected to boost the market. As a result, it is anticipated that the advanced wound dressing market in Europe would experience considerable expansion over the course of the projected period.
Within Europe, the Germany Advanced Wound Care Market is predicted to dominate the European sophisticated wound care industry and maintain its dominance during the forecast period, owing to advanced technology, increased government finances, and expenditures in wound care research that are propelling the market. Furthermore, rising demand for active wound care products and the treatment associated with them, especially in emerging markets, is expected to provide improved prospects. However, the procedure's cost is so high that it is unaffordable. In addition, insufficient reimbursement policies for the market may stifle this country's progress in this region.
The advanced wound care market in the United Kingdom is predicted to develop at a quick CAR throughout this time period, owing to the rising prevalence of diabetes, which is driving market expansion in this area. Other factors driving the market include lifestyle problems such as foot ulcers, pressure ulcers, and venous ulcers. Diabetes affects roughly 3.8 million individuals in the United Kingdom each year. Furthermore, the UK market is driven by product approvals and technological breakthroughs. Advanced Medical Solution Group plc, situated in the United Kingdom, has acquired FDA approval for high-performance dressings and silicone PHMB dressings, which will make it easier to market the goods in specified locations, thus influencing market growth.
Smith & Nephew PLC bought Osiris Therapeutics, Inc. in April 2019 with the goal of speeding up the development of its advanced wound management product range and broadening its client base and market reach.